Patents
2019 – S.C. De Smedt, R. Verbeke, H. Dewitte, I. Lentacker
Therapeutic nanoparticles and methods of use thereof – GALsomes
Priority date : 12/04/2019
Application number : EP19168853.0
2018 - K. Braeckmans, S.C. De Smedt, J. Fraire
Composition comprising at least one nanobomb suitable for altering a biological barrier
Priority date: 18/12/2018
Application number: EP18213548.3
2018 – S.C. De Smedt, K. Braeckmans, F. Sauvage
Composition of Treatment of vitreous disease or disorder
Priority: 08/10/2018
Application number: EP18199111.8
Entering PCT (not yet published)
2017 – K. Raemdonck, F. Joris, S. Stremersch, S. De Smedt
Molecular adjuvants for enhanced cytosolic delivery of active agents
Priority: 19/01/2017
Application number: EP17152264.2
Entering PCT (not yet published)
2016 - K. Raemdonck, S. De Smedt
Particles comprising surfactant protein B and one or more lipids
Priority: 24/11/2016
Application number: EP16200515.1
Entering PCT (not yet published)
2015 - A. Skirtach, J. Demeester, S. De Smedt, S. Stremersch, K. Raemdonck, K. Braeckmans
Method and system for characterizing extracellular vesicles
Entering PCT (not yet published)
2015 - K. Braeckmans, R. Xiong, S.K. Samal, S. De Smedt
Carbon-based particles for vapour bubble generation
Entering PCT
2014 - K. Braeckmans, S. De Smedt, J.Demeester, T. Coenye
Disruption or alteration of microbiological films
Entering PCT (not yet published)
2012 – K. Braeckmans, H. Deschout, J. Demeester, S.C. De Smedt
Method and system for dispersion measurements
Priority: 09/07/2010
Assigned in designated countries:
US9483440 (B2), EP2591333 (A1) under examination
Owner: UGent
2011 - K. Braeckmans, H. Deschout, K. Neyts, J. Demeester, S.C. De Smedt
Methods and systems for optical characterization
Priority
Assigned in designated countries:
US8928875 (B2), EP2513628 (A1) under examination
Owner: UGent
2010 - K. Braeckmans, H. Deschout, J. Demeester and S.C. De Smedt
Method and system for dispersion measurements
Priority:9/7/2010
Assigned in designated countries:
US9483440 (B2), EP2591333 still under examination
Owner: UGent
2010 - S.C. De Smedt, J. Demeester, C. Huang, B. Lucas
Encoded fibres
Priority: 18/12/2009
Assigned in designated countries:
WO2011073442 (A1) Withdrawn
2006 - S.C. De Smedt, J. Demeester, B. De Geest and S. Derveaux
Coating for microcarriers
Priority:20/10/2006
Assigned in designated countries:
EP1903337 (B1) withdrawn, JP5752881 (B2), US2010081215 (A1) still under examination (after ‘final rejection’)
Owner: Mycartis NV
2005 - S.C. De Smedt, J. Demeester and B. De Geest
Bio-agent delivery systems based on coated degradable biocompatible hydrogels
Priority:14/6/2005
Assigned in designated countries:
EP1733718 (A1)
2001 - N. Sanders, S. De Smedt and J. Demeester
Therapeutic compositions for the treatment of a respiratory tract disease
Priorty:13/4/2001
Assigned in designated countries:
US7432308 (B2)
2001 - B. Stubbe, S.C. De Smedt and J. Demeester
Pulsed bio-agent delivery systems based on degradable polymer solutions or hydrogels
Priority: 21/12/2001
Assigned in designated countries:
EP1455832 (B1)
2001 - K. Braeckmans, S.C. De Smedt, J. Demeester, C. Roelant and M. Leblans
Method and device for the manipulation of microcarriers for an identification purpose
Priority: 19/10/2000
Assigned in designated countries:
ZA200303008 (B), US8735172 (B2), RU2285265 (C2), NO337637 (B1), JP4404547 (B2), CA2425775 (C), EP2275819
Owner: Mycartis NV
1999 - S.C.. De Smedt and J. Demeester, C. Roeland and R. Pauwels
Encoding of microcarriers
Priority: 16/04/1999
Assigned in designated countries:
EP1173760 (B1), AU771517 (B2), CA2370315 (C), CN1271410 (C), US8967483 (B2) , ZA200108305 (B), RU2242746 (C2), JP4500455 (B2)
Owner: Mycartis NV